Manufacturing review: a review of manufacturing records was not performed, as additional complaints have not been reported for this lot.Based on the information available it is not reasonably suggested that a manufacturing process may have caused or contributed to the reported issue.However, the lot history records of this lot were reviewed with special attention to the manufacturing and inspection of this product and the product was found to have met the specification prior to shipment.Investigation summary: the sample was returned for evaluation.Based on the sample evaluation, the stent graft was partially deployed by about 2 mm.One of the stent struts perforated the outer sheath.Based on returned sample analysis, the investigation of the reported partial deployment is confirmed.Material perforation as reported was equally confirmed.It is reported that the system was flushed, device compatible accessories were used.A definite root cause for the reported event could not be determined.Labeling review: in reviewing the relevant labeling it was found that the instructions for use sufficiently address the potential risks.Regarding stent deployment, the instructions for use states "if resistance is encountered removing the delivery system, it is recommended to remove the delivery system, introducer and guidewire as a single unit".Regarding preparation of the device the instructions for use states that "prior to loading the endovascular system over a guide wire, both ports must be flushed with sterile saline to eliminate any air bubbles that may be trapped in the inner catheter lumen and/or the stent graft lumen.Flushing these lumens will also facilitate stent graft deployment".With regards to directions for use, the instructions for use states "prepare a stiff 0.035" guidewire per its instructions for use and advance the guidewire under fluoroscopy to the target location".Regarding the placement site, instructions for use states: ' vascular stent graft.For use in the iliac and femoral arteries'.Based on reported information, the intended placement site for this stent was the venous system which represents off-label use.D4 (expiry date: 08/2023).H11:section a through f - the information provided by bd represents all of the known information at this time.Despite good faith efforts to obtain additional information, the complainant / reporter was unable or unwilling to provide any further patient, product, or procedural details to bd.
|